drugset / Trial / NCT00755222
The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluated the safety and effectiveness of AA4500 in improving the impact of Peyronie's disease on quality of life and improving penile curvature in men with Peyronie's disease
Timeline
- Start
- 2008-08
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | — | Other |